Jeff Evans has been editor of Rheumatology News/MDedge Rheumatology and the EULAR Congress News since 2013. He started at Frontline Medical Communications in 2001 and was a reporter for 8 years before serving as editor of Clinical Neurology News and World Neurology, and briefly as editor of GI & Hepatology News. He graduated cum laude from Cornell University (New York) with a BA in biological sciences, concentrating in neurobiology and behavior.
News
Inflectra becomes first FDA-approved biosimilar for inflammatory diseases
News
Cutaneous lupus may raise risk of stroke, TIA
News
Parkinson’s disease psychosis drug gets favorable review from FDA advisory panel
News
Parkinson’s disease psychosis drug gets favorable review from FDA advisory panel
News
Lupus patients’ transition to adult care leaves gaps, delays in care
News
Home infusion policies called out in ACR position statement
News
Antisclerostin osteoporosis drugs might worsen or unmask rheumatoid arthritis
News
ACR’s 2016-2020 research agenda built through consensus
News
Registry study adds evidence for use of DMARD combo first in early RA
News
Once-daily tofacitinib formulation gets FDA clearance for RA
News
Anticancer drug bexarotene inhibits build-up of toxic Alzheimer’s protein
News
Fibromyalgia found in 20% with spondyloarthritis; could affect management decisions
News
Greater Myocardial Inflammation Found in RA Patients After Heart Attack
News
